Drug: Bevacizumab Injury: Thrombocytopenia Quarter: 2016Q3
Total Records: 44 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 89228356 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160914 | US | |
| 110923303 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160913 | IT | |
| 112724882 | BEVACIZUMAB | Thrombocytopenia | ACTAVIS | 72.63 YR | M | 69 KG | 20160704 | IT |
| 115525913 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160810 | JP | |
| 117884022 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160906 | US | |
| 122161853 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160907 | JP | |
| 123686475 | BEVACIZUMAB | Thrombocytopenia | MERCK | 8.00 YR | F | 0 | 20160712 | US |
| 124875442 | Bevacizumab | Thrombocytopenia | ROCHE | 34.66 YR | F | 55 KG | 20160907 | IT |
| 125281901 | BEVACIZUMAB | Thrombocytopenia | JANSSEN | 0.00 | 0 | 20160705 | US | |
| 125404372 | Bevacizumab | Thrombocytopenia | ROCHE | 66.00 YR | M | 55 KG | 20160808 | US |
| 125509871 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160713 | GR | |
| 125522631 | Bevacizumab | Thrombocytopenia | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125653661 | Bevacizumab | Thrombocytopenia | CELGENE | 0.00 | 0 | 20160718 | US | |
| 125732041 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160720 | JP | |
| 125826361 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160722 | US | |
| 125843591 | BEVACIZUMAB | Thrombocytopenia | MYLAN | 0.00 | 0 | 20160722 | IT | |
| 126099531 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160801 | US | |
| 126121851 | BEVACIZUMAB | Thrombocytopenia | SANDOZ | 28.00 YR | F | 0 | 20160801 | JP |
| 126128401 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126128551 | Bevacizumab | Thrombocytopenia | ROCHE | 0.00 | 0 | 20160802 | US |
Total Records: 44 Number of Pages: 3